|
CYB5R4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.280400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.331600E-01 |
| Normal-vs-Stage2 |
7.044400E-01 |
| Normal-vs-Stage3 |
1.690990E-01 |
| Normal-vs-Stage4 |
3.141600E-01 |
| Stage1-vs-Stage2 |
4.366200E-01 |
| Stage1-vs-Stage3 |
2.367800E-01 |
| Stage1-vs-Stage4 |
4.933600E-01 |
| Stage2-vs-Stage3 |
1.864350E-01 |
| Stage2-vs-Stage4 |
2.897400E-01 |
| Stage3-vs-Stage4 |
7.239400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.800200E-01 |
| Normal-vs-AfricanAmerican |
1.040480E-03 |
| Normal-vs-Asian |
6.272800E-01 |
| Caucasian-vs-AfricanAmerican |
1.206110E-04 |
| Caucasian-vs-Asian |
7.789400E-01 |
| AfricanAmerican-vs-Asian |
2.449000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.099800E-01 |
| Normal-vs-Female |
5.813600E-02 |
| Male-vs-Female |
1.905650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.447400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.928400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.264400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.776000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.371200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.513200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.426000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.436000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.907800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.103000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.746000E-01 |
| Normal-vs-Grade 2 |
6.416400E-01 |
| Normal-vs-Grade 3 |
3.752200E-01 |
| Normal-vs-Grade 4 |
2.012600E-01 |
| Grade 1-vs-Grade 2 |
3.970400E-01 |
| Grade 1-vs-Grade 3 |
6.139800E-01 |
| Grade 1-vs-Grade 4 |
9.562000E-01 |
| Grade 2-vs-Grade 3 |
6.493200E-01 |
| Grade 2-vs-Grade 4 |
3.251600E-01 |
| Grade 3-vs-Grade 4 |
4.458000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.172600E-01 |
| Normal-vs-ccB subtype |
4.569800E-01 |
| ccA subtype-vs-ccB subtype |
2.038400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.493000E-01 |
| Normal-vs-N1 |
5.230400E-01 |
| N0-vs-N1 |
3.874200E-01 |
|
|
